JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cot, A.
Right arrow Articles by Ros, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cot, A.
Right arrow Articles by Ros, D.
Journal of Nuclear Medicine Vol. 46 No. 9 1497-1504
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

Absolute Quantification in Dopaminergic Neurotransmission SPECT Using a Monte Carlo–Based Scatter Correction and Fully 3-Dimensional Reconstruction

Albert Cot, PhD1,2, Carles Falcón, PhD1, Cristina Crespo, MSc1, Josep Sempau, PhD3, Deborah Pareto, PhD1, Santiago Bullich, PhD1, Francisco Lomeña, MD, PhD4,5, Francisco Calviño, PhD2, Javier Pavía, PhD4,5 and Domènec Ros, PhD1,5

1 Unitat de Biofísica i Bioenginyeria, Departament Ciències Fisiològiques I, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
2 Secció d’Enginyeria Nuclear, Departament Física i Enginyeria Nuclear, Universitat Politècnica de Catalunya, Barcelona, Spain
3 Institut de Tècniques Energètiques, Universitat Politècnica de Catalunya, Barcelona, Spain
4 Servei de Medicina Nuclear, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
5 Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

Dopamine transporter (DAT) ligands have been developed for in vivo imaging of the dopaminergic system in SPECT. Although the visual analysis of SPECT images is, in general, suitable for clinical assessment, the accurate quantification of the striatal uptake might increase the sensitivity of the technique and help in the early diagnosis, follow-up, and eventual treatment response of Parkinson’s disease (PD). This work is focused on assessment of the quantification of specific uptake of 99mTc-DAT ligands when compensation for all degrading phenomena is performed. Methods: The SimSET Monte Carlo (MC) code was used to generate a set of SPECT projections of a numeric striatal phantom with different specific uptake ratios (SURs). An absolute quantification method (AQM), which performs a MC-based scatter compensation and a fully 3-dimensional (3D) reconstruction, was implemented. The scatter estimate was included in the reconstruction algorithm. Results: The use of attenuation, point-spread-function (PSF), and scatter corrections resulted in an improvement in the value of the SUR of 37% on average with respect to the reconstruction without corrections. The magnitude of each improvement corresponded to 7% for the attenuation correction, 12% for the PSF correction using a 2-dimensional reconstruction algorithm and a further 11% for the PSF correction using a 3D reconstruction algorithm, and 7% for the scatter correction. Conclusion: Our findings indicate that the PSF correction plays a major role in the quantification of striatal uptake in comparison with the attenuation correction and the scatter correction. The implemented method also provides an absolute quantification procedure based on MC methods that do not depend on empiric approximations. The relative quantification results using the proposed AQM accounted for 96%–97% of the nominal SUR, whereas the limit achieved using only primary photons attained 98%–99%. The volumetric activity values obtained using the AQM converged toward the nominal values.

Key Words: scatter correction • fully 3D reconstruction • dopamine transporter • Monte Carlo methods


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.